SCHEMBL31545321

SCHEMBL31545321

CCCc1ccc(C(CCC)c2ccc(CCC)cc2O)c(O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.52
CNR2 P34972 1/20 0.52
CYP2D6 P10635 2/20 0.41
ALOX5 P09917 1/20 0.41
TP53 P04637 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
CYP2C19 P33261 1/20 0.41
CYP3A4 P08684 1/20 0.41
DRD2 P14416 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
DRD1 P21728 1/20 0.41
DRD4 P21917 1/20 0.41
DRD5 P21918 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
DRD3 P35462 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4595798 0.87 TRPA1 (0.53) CNR1CNR2CYP2D6ALOX5TP53
SCHEMBL4595834 0.86 CNR1 (0.56) CNR1CNR2CYP2D6ALOX5TP53
SCHEMBL5168817 0.81 CNR1 (0.55) CNR1CNR2CYP2D6ALOX5TP53
SCHEMBL4596678 0.79 TYR (0.50) CYP2D6ALOX5TP53CYP2C9ALOX15
SCHEMBL16736785 0.79 TSHR (0.53) CNR1CNR2CYP2D6ALOX5TP53
SCHEMBL4595527 0.78 TRPA1 (0.57) CNR1CNR2CYP2D6TP53CYP2C9
SCHEMBL4594942 0.75 TRPA1 (0.48) CYP2D6TP53CYP2C9ALOX15CYP2C19
SCHEMBL57143 0.74 CNR1 (0.72) CNR1CNR2CYP2D6ALOX5TP53
SCHEMBL30309851 0.74 CNR1 (0.72) CNR1CNR2CYP2D6ALOX5TP53
SCHEMBL340067 0.74 CNR1 (0.72) CNR1CNR2CYP2D6ALOX5TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 US disclosed